Mid Atlantic Financial Management’s Novartis NVS Stock Holding History

Mid Atlantic Financial Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$372K	Sell	4,546 -128	-3%	-$11.5K	0.02%	566
2021 Q2	$426K	Sell	4,674 -28	-0.6%	-$2.49K	0.03%	529
2021 Q1	$402K	Buy	4,702 +55	+1%	+$4.94K	0.03%	511
2020 Q4	$439K	Buy	4,647 +125	+3%	+$10.9K	0.03%	429
2020 Q3	$380K	Sell	4,522 -408	-8%	-$35.3K	0.03%	432
2020 Q2	$431K	Buy	4,930 +10	+0.2%	+$863	0.04%	377
2020 Q1	$406K	Sell	4,920 -591	-11%	-$52.7K	0.05%	354
2019 Q4	$522K	Sell	5,511 -36	-0.6%	-$3.23K	0.05%	371
2019 Q3	$482K	Sell	5,547 -649	-10%	-$58.3K	0.05%	364
2019 Q2	$566K	Sell	6,196 -666	-10%	-$56.4K	0.06%	337
2019 Q1	$591K	Sell	6,862 -1,427	-17%	-$115K	0.06%	323
2018 Q4	$637K	Buy	+8,289	New	+$645K	0.08%	268

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Mid Atlantic Financial Management's NVS Position: Q3 2021 in Review

Mid Atlantic Financial Management reduced its Novartis (NVS) stake by 2.7% in Q3 2021, selling an estimated $11.5K and leaving 4,546 shares worth $372K. The position accounts for 0.02% of the portfolio, ranked #566.

Mid Atlantic Financial Management first reported a position in NVS in Q4 2018 and has held it in 12 quarters since. The position peaked at $637K in Q4 2018. 1,081 funds tracked by Wall St. Rank hold NVS as of Q3 2021.

Mid Atlantic Financial Management held 4,546 shares of Novartis worth $372K as of Q3 2021.
Mid Atlantic Financial Management sold 128 Novartis shares in Q3 2021, an estimated $11.5K.
Novartis made up 0.02% of Mid Atlantic Financial Management's portfolio in Q3 2021, its #566 holding.
Mid Atlantic Financial Management first reported a position in Novartis in Q4 2018 and has held it in 12 quarters since.
Mid Atlantic Financial Management's Novartis position peaked at $637K in Q4 2018.
1,081 funds tracked by Wall St. Rank held Novartis as of Q3 2021.

Based on Mid Atlantic Financial Management's 13F filing for Q3 2021, filed 12 Nov 2021.